IGHE and Nasal polyposis: Omalizumab demonstrated clinical efficacy in the treatment of nasal polyps with comorbid asthma, supporting the importance and functionality of local IgE formation in the airways [76], but in our study, no change was seen on nasal polyposis after omalizumab treatment [21].